A progressive lung disease characterized by scarring (fibrosis) of the lung tissue, idiopathic pulmonary fibrosis (IPF) has no known cause and leads to worsening breathlessness and reduced oxygen exchange. The primary use of this diagnosis is guiding treatment plans, including antifibrotic medications and lung transplantation referrals. Patients, typically older adults, benefit from early detection to slow disease progression and improve quality of life.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends